These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 30282449

  • 1. Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
    Nam AR, Kim JW, Park JE, Bang JH, Jin MH, Oh DY, Bang YJ.
    Cancer Res Treat; 2019 Jul; 51(3):886-900. PubMed ID: 30282449
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
    Wang S, Oh DY, Leventaki V, Drakos E, Zhang R, Sahin AA, Resetkova E, Edgerton ME, Wu W, Claret FX.
    Cancer Lett; 2019 Nov 28; 465():12-23. PubMed ID: 31473252
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51.
    Liu G, Yu M, Wu B, Guo S, Huang X, Zhou F, Claret FX, Pan Y.
    Cell Signal; 2019 Jan 28; 53():39-48. PubMed ID: 30244171
    [Abstract] [Full Text] [Related]

  • 11. The novel Jab1 inhibitor CSN5i-3 suppresses cell proliferation and induces apoptosis in human breast cancer cells.
    Xiao H, Claret FX, Shen Q.
    Neoplasma; 2019 May 23; 66(3):481-486. PubMed ID: 30868895
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
    Pan Y, Wang S, Su B, Zhou F, Zhang R, Xu T, Zhang R, Leventaki V, Drakos E, Liu W, Claret FX.
    Oncogene; 2017 Feb 23; 36(8):1069-1079. PubMed ID: 27524414
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
    Shen Q, Shang B, Jiang B, Wang Y, Wang Z, Chen G.
    Thorac Cancer; 2020 Apr 23; 11(4):973-982. PubMed ID: 32064781
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.
    Ahn J, Hong SA, Lee SE, Kim J, Oh YS, Park SJ, Chung YJ.
    Endocr J; 2009 Apr 23; 56(5):707-13. PubMed ID: 19461157
    [Abstract] [Full Text] [Related]

  • 17. JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer.
    Danielpour D, Purighalla S, Wang E, Zmina PM, Sarkar A, Zhou G.
    Biochem Biophys Res Commun; 2019 Oct 15; 518(2):374-380. PubMed ID: 31434609
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.
    Tomoda K, Kato JY, Tatsumi E, Takahashi T, Matsuo Y, Yoneda-Kato N.
    Blood; 2005 Jan 15; 105(2):775-83. PubMed ID: 15353483
    [Abstract] [Full Text] [Related]

  • 20. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
    Shackleford TJ, Zhang Q, Tian L, Vu TT, Korapati AL, Baumgartner AM, Le XF, Liao WS, Claret FX.
    Breast Cancer Res; 2011 Jun 20; 13(3):R65. PubMed ID: 21689417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.